文献速递胸部肿瘤

NUSAP1在非小细胞肺癌中的表达及其与预后的关系

[Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

该研究检测50例非小细胞肺癌及癌旁组织中NUSAP1的mRNA与蛋白表达,并结合在线数据库分析其与预后的关系。结果显示癌组织NUSAP1表达显著升高,且高表达与肿瘤大小、淋巴结转移、TNM分期相关;mRNA表达与总生存相关,提示其可能作为潜在预后标志物。

要点

  • NUSAP1在NSCLC癌组织中mRNA和蛋白表达均高于癌旁组织。
  • NUSAP1蛋白高表达与肿瘤大小、淋巴结转移和TNM分期相关。
  • NUSAP1 mRNA低表达患者总生存较长,或可作预后标志物。

核心结论

  • NUSAP1在非小细胞肺癌中表达上调,与肿瘤生长发展及患者预后相关,可作为潜在预后标志物。

研究设计与样本

  • 收集非小细胞肺癌及癌旁组织标本各50例,采用实时荧光定量PCR检测NUSAP1 mRNA,免疫组化法检测蛋白。
  • 采用在线数据库分析NUSAP1表达与NSCLC患者预后的关系。

主要发现

  • 肺癌组织中NUSAP1 mRNA表达水平高于癌旁组织(P<0.05)。
  • NUSAP1蛋白在癌组织中高表达率为58.0%(29/50),癌旁组织为22.0%(11/50),差异有统计学意义(P<0.05)。
  • NUSAP1蛋白表达与年龄和性别无关(均P>0.05),与肿瘤大小、淋巴结转移和TNM分期有关(均P<0.05)。
  • 在线数据库显示NUSAP1 mRNA表达与总生存有关(P<0.001),低表达患者OS较长。
  • NUSAP1 mRNA表达与病理分级、临床分期、性别、化疗、吸烟史和组织分型均有关(均P<0.05)。

临床怎么用

  • NUSAP1免疫组化或可作为NSCLC预后评估的候选补充指标,需结合分期等临床病理特征解读。
  • NUSAP1高表达提示与肿瘤大小、淋巴结转移及较晚TNM分期相关,可用于风险分层探索。

局限性

  • 组织样本量较小(癌与癌旁各50例),预后分析主要基于在线数据库而非同一队列随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the expression of nucleolar and spindle-associated protein 1 (NUSAP1) in non-small cell lung cancer (NSCLC) and analyze its relationship with the prognosis of NSCLC patients. Methods: Real-time fluorescent quantitative PCR and immunohistochemical staining were performed to determine the expression of NUSAP1 in NSCLC tissues and adjacent tissues collected from hospital. The relationship between NUSAP1 expression and prognosis of NSCLC patients was analyzed by online database. Results: The expression level of NUSAP1 mRNA in tumor tissues was significantly higher than that of adjacent tissues (P<0.05). The high expression rate of NUSAP1 protein in NSCLC tissues was 58.0% (29/50), significantly higher than 22.0% (11/50) of adjacent tissues (P<0.05). The high expression of NUSAP1 protein in NSCLC tissues was closely correlated with tumor size, lymph node metastasis and TNM stage (P<0.05), but was not related to age and gender. The data showed that the expression level of NUSAP1 mRNA was inversely associated with the overall survival (OS) of NSCLC patients (P<0.001). The expression of NUSAP1 mRNA was significantly correlated with the pathological grade, clinical stage, gender, chemotherapy, smoking history, and histological type of NSCLC patients (P<0.05). Conclusions: The expression of NUSAP1 is up-regulated in NSCLC, which is correlated with the growth and development of NSCLC and prognosis of the patients. These results indicate that NUSAP1 can be used as a potential prognostic marker for NSCLC. 目的: 探讨核仁纺锤体相关蛋白1(NUSAP1)在非小细胞肺癌中的表达及其与患者预后的关系。 方法: 收集非小细胞肺癌及癌旁组织标本各50例,采用实时荧光定量PCR检测NUSAP1 mRNA的表达,采用免疫组化法检测NUSAP1蛋白的表达,采用在线数据库分析NUSAP1的表达及其与非小细胞肺癌患者预后的关系。 结果: 肺癌组织中NUSAP1 mRNA的表达水平高于癌旁组织(P<0.05);NUSAP1蛋白在癌组织中的表达率为58.0%(29/50),在癌旁组织中的表达率为22.0%(11/50),差异有统计学意义(P<0.05)。NUSAP1蛋白的表达与患者的年龄和性别均无关(均P>0.05),但与肿瘤大小、淋巴结转移和TNM分期均有关(均P<0.05)。在线数据库分析显示,NUSAP1 mRNA的表达水平与患者的总生存时间(OS)有关(P<0.001);与NUSAP1高表达的患者比较,低表达患者的OS较长。Kaplan-Meier plotter在线数据库分析显示,NUSAP1 mRNA的表达与患者病理分级、临床分期、性别、化疗、吸烟史和组织分型均有关(均P<0.05)。 结论: NUSAP1在非小细胞肺癌组织中过表达,与肿瘤的生长发展和患者的预后有关,可作为非小细胞肺癌患者潜在的预后标志物。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yu Z, Li XM, Huai M, et al. [Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31357839. doi:10.3760/cma.j.issn.0253-3766.2019.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。